QQQ   431.52 (+0.11%)
AAPL   169.65 (-1.76%)
MSFT   415.99 (+0.57%)
META   500.34 (+0.02%)
GOOGL   154.77 (-0.06%)
AMZN   183.57 (-0.03%)
TSLA   155.97 (-3.41%)
NVDA   873.07 (+1.52%)
AMD   163.30 (+1.86%)
NIO   3.84 (-1.29%)
BABA   70.05 (-0.81%)
T   16.00 (-1.48%)
F   12.15 (-0.65%)
MU   121.17 (-0.16%)
GE   155.55 (+1.20%)
CGC   6.78 (-2.87%)
DIS   113.88 (+0.82%)
AMC   2.81 (+13.77%)
PFE   25.79 (-0.46%)
PYPL   63.73 (+0.35%)
XOM   118.36 (-1.10%)
QQQ   431.52 (+0.11%)
AAPL   169.65 (-1.76%)
MSFT   415.99 (+0.57%)
META   500.34 (+0.02%)
GOOGL   154.77 (-0.06%)
AMZN   183.57 (-0.03%)
TSLA   155.97 (-3.41%)
NVDA   873.07 (+1.52%)
AMD   163.30 (+1.86%)
NIO   3.84 (-1.29%)
BABA   70.05 (-0.81%)
T   16.00 (-1.48%)
F   12.15 (-0.65%)
MU   121.17 (-0.16%)
GE   155.55 (+1.20%)
CGC   6.78 (-2.87%)
DIS   113.88 (+0.82%)
AMC   2.81 (+13.77%)
PFE   25.79 (-0.46%)
PYPL   63.73 (+0.35%)
XOM   118.36 (-1.10%)
QQQ   431.52 (+0.11%)
AAPL   169.65 (-1.76%)
MSFT   415.99 (+0.57%)
META   500.34 (+0.02%)
GOOGL   154.77 (-0.06%)
AMZN   183.57 (-0.03%)
TSLA   155.97 (-3.41%)
NVDA   873.07 (+1.52%)
AMD   163.30 (+1.86%)
NIO   3.84 (-1.29%)
BABA   70.05 (-0.81%)
T   16.00 (-1.48%)
F   12.15 (-0.65%)
MU   121.17 (-0.16%)
GE   155.55 (+1.20%)
CGC   6.78 (-2.87%)
DIS   113.88 (+0.82%)
AMC   2.81 (+13.77%)
PFE   25.79 (-0.46%)
PYPL   63.73 (+0.35%)
XOM   118.36 (-1.10%)
QQQ   431.52 (+0.11%)
AAPL   169.65 (-1.76%)
MSFT   415.99 (+0.57%)
META   500.34 (+0.02%)
GOOGL   154.77 (-0.06%)
AMZN   183.57 (-0.03%)
TSLA   155.97 (-3.41%)
NVDA   873.07 (+1.52%)
AMD   163.30 (+1.86%)
NIO   3.84 (-1.29%)
BABA   70.05 (-0.81%)
T   16.00 (-1.48%)
F   12.15 (-0.65%)
MU   121.17 (-0.16%)
GE   155.55 (+1.20%)
CGC   6.78 (-2.87%)
DIS   113.88 (+0.82%)
AMC   2.81 (+13.77%)
PFE   25.79 (-0.46%)
PYPL   63.73 (+0.35%)
XOM   118.36 (-1.10%)

Connect Biopharma (CNTB) SEC Filings & 10K Form

$1.71
+0.04 (+2.40%)
(As of 02:09 PM ET)

Recent Connect Biopharma SEC Filings

DateFilerForm TypeView
02/27/2024
8:00 PM
Connect Biopharma (Subject)
Panacea Innovation Ltd (Filed by)
Form SC 13D/A
02/13/2024
3:18 PM
Connect Biopharma (Subject)
Wei Zheng (Filed by)
Form SC 13G/A
12/20/2023
3:30 PM
Connect Biopharma (Subject)
RA CAPITAL MANAGEMENT, L.P. (Filed by)
Form SC 13D/A
12/18/2023
5:44 PM
Connect Biopharma (Subject)
RA Capital Nexus Fund, L.P. (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
12/18/2023
5:09 PM
Connect Biopharma (Subject)
RA Capital Healthcare Fund LP (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
12/14/2023
3:30 PM
Connect Biopharma (Subject)
RA CAPITAL MANAGEMENT, L.P. (Filed by)
Form SC 13D/A
12/12/2023
6:40 PM
Connect Biopharma (Subject)
RA Capital Nexus Fund, L.P. (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
12/12/2023
6:05 PM
Connect Biopharma (Subject)
RA Capital Healthcare Fund LP (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
12/12/2023
5:10 AM
Connect Biopharma (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
12/04/2023
4:20 PM
Connect Biopharma (Subject)
RA CAPITAL MANAGEMENT, L.P. (Filed by)
Form SC 13D/A
11/27/2023
6:32 PM
Connect Biopharma (Subject)
RA Capital Healthcare Fund LP (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
11/27/2023
6:49 PM
Connect Biopharma (Subject)
RA Capital Nexus Fund, L.P. (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
11/21/2023
5:58 PM
Connect Biopharma (Subject)
RA Capital Healthcare Fund LP (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
11/21/2023
6:09 PM
Connect Biopharma (Subject)
RA Capital Nexus Fund, L.P. (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
11/21/2023
5:13 AM
Connect Biopharma (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
10/20/2023
3:44 PM
Connect Biopharma (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
10/04/2023
4:26 PM
Connect Biopharma (Subject)
Huang James (Filed by)
Form SC 13G/A
09/12/2023
3:47 PM
Connect Biopharma (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
09/12/2023
5:13 AM
Connect Biopharma (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
07/14/2023
4:00 PM
Connect Biopharma (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
06/23/2023
3:31 PM
Connect Biopharma (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
06/01/2023
3:24 PM
Connect Biopharma (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
(Data available from 1/1/2016 forward)


Related Companies and Tools

This page (NASDAQ:CNTB) was last updated on 4/16/2024 by MarketBeat.com Staff

From Our Partners